During tumor‐killing assays, anti‐CD24 neutralizing antibodies significantly rescued the Siglec‐G‐mediated inhibition of CD8+ T cells cytotoxicity (Figure S10K, Supporting Information). This evidence concerns the gene CD8A and neoplasm.